Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01184118 · ClinicalTrials.gov registry record · NA
DREAM: Does Inhaled Fluticasone REsult in Obstructive Sleep Apnea Manifestations?
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01184118 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 36 participants.
The verdict
NCT01184118, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study is being conducted to find out if the use of inhaled corticosteroids has an affect on upper airway (UAW) collapsibility and sleep apnea risk. An inhaled corticosteroid is a common asthma controller medication like Flovent. Sleep apnea or sleep deprived breathing (SDB) is when someone stops breathing for a short period of time during sleep. For some reason, people with asthma have more sleep apnea and upper airway (UAW) collapsibility (weakness) than the general population. There are many possible reasons for this and one might be related to the use of inhaled corticosteroids. The overall hypothesis of this study is to determine whether inhaled fluticasone propionate (FP) increases UAW collapsibility and to assess tongue (genioglossus muscle) dysfunction as a potential underlying mechanism.
Interventions
- DRUG FP 220 mcg 2 puffs BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01184118
The ClinicalTrials.gov registry entry for NCT01184118 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FP 220 mcg 2 puffs BID is the first listed.
NCT01184118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01184118 about?
NCT01184118 is a clinical study titled "DREAM: Does Inhaled Fluticasone REsult in Obstructive Sleep Apnea Manifestations?". This study is being conducted to find out if the use of inhaled corticosteroids has an affect on upper airway (UAW) collapsibility and sleep apnea risk. An inhaled corticosteroid is a common asthma controller medication like Flovent. Sleep apnea or sleep deprived breathing (SDB) is when someone stop...
What is the current status of trial NCT01184118?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2009-03. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01184118?
The interventions under investigation include: FP 220 mcg 2 puffs BID (DRUG).
Who is sponsoring clinical trial NCT01184118?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.